Journals / Turkish Journal of Clinics and Laboratory / 2019 / Cilt: 10 - Sayı: 1

A different view of normocalcemic hyperparathyroidism: The examination of cardiac problems

Normokalsemik hiperparatiroidiye farklı bakış: Kardiyak sorunların gözden geçirilmesi

Pages
104–109
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

İn this review, it is intended to raise a concern about cardiac complications occuring in primary hyperparathyroidism.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:While hyperparathyroidism is well known among the clinicians, such side effects as renal complications and osteoporosis are closely monitored.
📊
Key Findings & Data:Even some studies have pointed to increase in cardiac mortality is correlated with hyperparathyroidizm.
💡
Conclusion & Impact:İn this review, it is intended to raise a concern about cardiac complications occuring in primary hyperparathyroidism.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Hiperparatiroidi · kardiyak etkiler · hipertansiyon

Abstract

While hyperparathyroidism is well known among the clinicians, such side effects as renal complications and osteoporosis are closely monitored. Besides various conducted studies have found out several side effects such as hypertension, diastolic dysfunction, endothelial dysfunction, heart valve calcification, arythmia, cardiac hypertropy. Even some studies have pointed to increase in cardiac mortality is correlated with hyperparathyroidizm. İn this review, it is intended to raise a concern about cardiac complications occuring in primary hyperparathyroidism.

Özet

Hiperparatiroidi klinisyenler tarafından iyi bilinen bir hastalık olmakla birlikte öncelikle renal komplikasyonlar ve osteoporoz gibi yan etkiler yakın takip edilmektedir. Bununla birlikte yapılan çeşitli çalışmalarda hiperparatiroidiye bağlı hipertansiyon, diastolik disfonksiyon, endotel disfonksiyonu, kalp kapak kalsifkasyonu, aritmi, kardiyak hipertrofi gibi yan etkiler belirtilmiştir. Hatta bazı çalışmalar kardiyak mortalite artışıyla ilişkili bulunmuştur. Bu derlemede primer hiperparatiroidide rastlanan kardiyak sorunlara dikkat çekmek amaçlanmıştır.

🔖

Cite This Article

ALP, Ç., KARAHAN, İ., DURMAZ, Ş. (2019). A different view of normocalcemic hyperparathyroidism: The examination of cardiac problems. Turkish Journal of Clinics and Laboratory, Cilt: 10 - Sayı: 1, 104–109. https://ajindex.com/articles/372816

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease--a review. Eur Heart J 2004
  2. Kalla A, Krishnamoorthy P, Gopalakrishnan A, Garg J, Patel NC, Figueredo VM. Primary hyperparathyroidism predicts hypertension: Results from the National Inpatient Sample. Int J Cardiol 2017
  3. 37 3. Heath III, Hunter, Stephen F. Hodgson, Margaret A. Kennedy. "Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community." Nejm 1980
  4. Amanzadeh J, Reilly RF Jr. Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nat Clin Pract Nephrol 2006
  5. Fardella C, Rodriguez-Portales JA. Intracellular calcium and blood pressure: comparison between primary hyperparathyroidism and essential hypertension. J Endocrinol Invest 1995
  6. Gennari C, Nami R, Gonnelli S. Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems. Miner Electrolyte Metab 1995
  7. Osto E, Fallo F, Pelizzo MR et al. Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy. Circulation 2012
  8. Ozdemir D, Kalkan GY, Bayram NA et al. Evaluation of left ventricle functions by tissue Doppler, strain, and strain rate echocardiography in patients with primary hyperparathyroidism. Endocrine 2014
  9. J.L. Anderson, R.C. Vanwoerkom, B.D. Horne, T.L. Bair, H.T. May, D.L. Lappé, J.B. Muhlestein, Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am. Heart J 2011
  10. D. Han, S. Trooskin, X. Wang, Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism. J. Endocrinol. Invest 2012
  11. Stefenelli T, Abela C, Frank H et al. Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab 1997
  12. Palmer M, Adami HO, Bergström R, Jakobsson S, Akerström G, Ljunghall S. Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up. Lancet 1987
  13. Hagstrom M, Hellman EP, Larsson TE et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009
  14. Buizert PJ, van Schoor NM, Simsek S et al. PTH: a new ta